Probiodrug - Company & Market Research Reports

Probiodrug AG is a biopharmaceutical company focused on the development and commercialisation of new therapeutic products for the treatment of Alzheimer's disease. Headquartered in Halle, Germany, Probiodrug was founded in 1997 by Prof Dr. Hans-Ulrich Demuth and Dr. Konrad Glund and successfully developed a novel therapeutic concept for diabetes – the DP4 inhibitors / gliptins. Today, the company's lead product candidate is PQ912, an inhibitor of QC for Alzheimer animal models.

Alzheimer's Disease: Clinical Pipelines, R&D Challenges, and Future Directions - Product Thumbnail Image

Alzheimer's Disease: Clinical Pipelines, R&D Challenges, and Future Directions

  • Report
Non-Insulin Therapies for Diabetes: GLP-1 Agonists, DPP4 Inhibitors and SGLT2 Inhibitors, 2016 - 2026 - Product Thumbnail Image

Non-Insulin Therapies for Diabetes: GLP-1 Agonists, DPP4 Inhibitors and SGLT2 Inhibitors, 2016 - 2026

  • Report
  • 359 Pages
From
Cognitive Impairment Disorders Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Cognitive Impairment Disorders Drug Development Pipeline Review, 2018

  • Report
  • 376 Pages
From
Huntington Disease - Pipeline Review, H2 2017 - Product Thumbnail Image

Huntington Disease - Pipeline Review, H2 2017

  • Report
  • 287 Pages
From
Huntington Disease - Pipeline Review, H1 2017 - Product Thumbnail Image

Huntington Disease - Pipeline Review, H1 2017

  • Report
  • 299 Pages
From
Alzheimer's Disease Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Alzheimer's Disease Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 833 Pages
From
Cyclin-Dependent Kinase 9 (CDK9) Inhibitor -Pipeline Insight, 2018 - Product Thumbnail Image

Cyclin-Dependent Kinase 9 (CDK9) Inhibitor -Pipeline Insight, 2018

  • Drug Pipelines
  • 90 Pages
From
Probiodrug AG - Product Pipeline Review - 2015 - Product Thumbnail Image

Probiodrug AG - Product Pipeline Review - 2015

  • Company Profile
  • 23 Pages
From
Probiodrug AG (PBD) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Probiodrug AG (PBD) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • 25 Pages
From
Probiodrug AG Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis - Product Thumbnail Image

Probiodrug AG Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

  • Company Profile
  • 30 Pages
From
Probiodrug AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report - Product Thumbnail Image

Probiodrug AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • Mergers and Acquisitions Profiles
  • 37 Pages
From
  • 11 Results (Page 1 of 1)
Loading Indicator
adroll